MELA Sciences

MELA Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.

MELA Sciences, Inc.
Public
Traded asNASDAQ: MELA
Headquarters
Irvington, New York
,
United States
Websitemelasciences.com

The company’s flagship product, MelaFind®, is intended to be used when a trained dermatologist chooses to obtain additional information to help decide whether to biopsy certain clinically atypical pigmented skin lesions. Following completion of a successful conformity assessment procedure, MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.[1]

In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County.[2]

References
  1. "Case - Mela Sciences Inc". Pomeranz Law. Archived from the original on 17 November 2012. Retrieved 17 November 2012.
  2. George, John. "Exclusive: N.Y. medical device firm moving to Montco" Philadelphia Business Journal (July 15, 2015)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.